Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vsee Health (VSEE) Notes Payables (2023 - 2025)

Vsee Health (VSEE) has disclosed Notes Payables for 3 consecutive years, with $3.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Notes Payables rose 3037.81% year-over-year to $3.8 million, compared with a TTM value of $3.8 million through Sep 2025, up 3037.81%, and an annual FY2024 reading of $2.1 million, up 795.74% over the prior year.
  • Notes Payables was $3.8 million for Q3 2025 at Vsee Health, up from $2.5 million in the prior quarter.
  • Across five years, Notes Payables topped out at $3.8 million in Q3 2025 and bottomed at $122000.0 in Q3 2024.
  • Average Notes Payables over 3 years is $1.2 million, with a median of $397408.0 recorded in 2024.
  • The sharpest move saw Notes Payables tumbled 33.26% in 2024, then skyrocketed 3037.81% in 2025.
  • Year by year, Notes Payables stood at $233774.0 in 2023, then skyrocketed by 795.74% to $2.1 million in 2024, then surged by 82.81% to $3.8 million in 2025.
  • Business Quant data shows Notes Payables for VSEE at $3.8 million in Q3 2025, $2.5 million in Q2 2025, and $2.6 million in Q1 2025.